Brexit could affect how quickly new medicines are made available to patients

We lag behind other European countries in how quickly new medicines are made available to patients and this could be exacerbated by Brexit, says Bernard Mallee.

Brexit could affect how quickly new medicines are made available to patients

We lag behind other European countries in how quickly new medicines are made available to patients and this could be exacerbated by Brexit, says Bernard Mallee.

Earlier this week, Taoiseach Leo Varadkar raised the prospect of a shortage of medicines in Ireland, should Britain and the European Union fail to agree plans, including on trade, for an exit deal.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Revoiced

Newsletter

Had a busy week? Sign up for some of the best reads from the week gone by. Selected just for you.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited